Brief: Cipla Preparing For Gsymbicort, And A Couple Of Inhalation Assets Launch In FY27
July 25 (Reuters) - Cipla Ltd CIPL.NS: CIPLA - PREPARING FOR GSYMBICORT, AND A COUPLE OF INHALATION ASSETS LAUNCH IN FY27 CIPLA - BUSINESS REMAIN COMMITTED TO LAUNCHING 2–3 PEPTIDE ASSETS IN FY26 Source text: ID:nNSE5YkzmP Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated